Eric Ende is joining the Matinas BioPharma Holdings Inc. board April 3.
Ende is the president of Ende BioMedical Consulting Group.
Matinas BioPharma appoints director
Identifying PPE Suppliers During the Pandemic
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
Matinas BioPharma appoints director
- Author Ephraim Bie
- Theme Healthcare & Pharmaceuticals
- Author
- Ephraim Bie
- Theme
- Healthcare & Pharmaceuticals